We are live on ! Find out more
ERB

ERBA DIAGNOSTICS
ERB

Delisted

ERB was delisted on the 29th of September, 2016.

2 hedge funds and large institutions have $56K invested in ERBA DIAGNOSTICS in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less funds holding

Funds holding: 122 (-10)

91% less capital invested

Capital invested by funds: $647K → $56K (-$591K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
2
Holders Change
-10
Holders Change %
-83.33%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
10
Calls
Puts
Net Calls
Net Calls Change

ERB Hedge Fund Activity: Q3 2016 in Review

2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ERBA DIAGNOSTICS (ERB) for Q3 2016, worth a combined $56K — down 91% from $647K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ERB and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $240K sold.

  • 2 institutional investors held ERBA DIAGNOSTICS (ERB) as of Q3 2016, down from 12 in Q2 2016.
  • Funds reported $56K of ERBA DIAGNOSTICS stock for Q3 2016, down 91% quarter-over-quarter.
  • 0 funds opened new ERBA DIAGNOSTICS positions in Q3 2016 and 10 closed out, a net change of -10 holders.
  • The largest ERBA DIAGNOSTICS seller in Q3 2016 was Vanguard Group, an estimated $240K sold.

Based on aggregated 13F filings for Q3 2016.